FEMASYS INC. - COMMON STOCK

Femasys Announces Financial Results for Year Ended December 31, 2024, and Provides Corporate Update

27 Mar 2025 09:00:00 By Nasdaq GlobeNewswire

Femasys Announces Partnership with CNY Fertility, National Conglomerate Network of Fertility Centers, to Offer FemaSeed in its 11 Locations

19 Mar 2025 09:20:00 By Nasdaq GlobeNewswire

Femasys Secures Distribution Partnerships for Commercialization of FemBloc® in Spain

18 Mar 2025 09:00:00 By Nasdaq GlobeNewswire

Femasys Announces FemBloc Delivery System Approval in Europe; A Significant Step Towards FemBloc Permanent Birth Control Availability as the First-Ever Non-Surgical Approach

13 Mar 2025 08:30:00 By Nasdaq GlobeNewswire

Femasys Announces Peer-Reviewed Publication of Positive Safety and Efficacy Results from FemBloc® Permanent Birth Control Clinical Trials

25 Feb 2025 09:20:00 By Nasdaq GlobeNewswire

Femasys Announces UK Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices

11 Feb 2025 09:00:00 By Nasdaq GlobeNewswire

Femasys Announces Israeli Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices

04 Feb 2025 09:00:00 By Nasdaq GlobeNewswire

Femasys Announces Notices of Intention to Grant for Two New European Patent Applications Covering Use of FemBloc Permanent Birth Control

30 Jan 2025 08:30:00 By Nasdaq GlobeNewswire

Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemaSeed® for Female Infertility Treatment

16 Jan 2025 08:30:00 By Nasdaq GlobeNewswire

Femasys Announces Partnership with HRC Fertility, Esteemed Conglomerate Provider of Fertility Services in Western U.S., to Offer FemaSeed

03 Dec 2024 09:00:00 By Nasdaq GlobeNewswire

Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility Treatment

26 Nov 2024 08:30:00 By Nasdaq GlobeNewswire

Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update

12 Nov 2024 08:30:00 By Nasdaq GlobeNewswire

Femasys to Exhibit at the Annual AAGL 2024 Global Conference

07 Nov 2024 08:30:00 By Nasdaq GlobeNewswire

Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth Control

01 Nov 2024 08:30:00 By Nasdaq GlobeNewswire

Femasys Announces Partnership with Boston IVF, Prominent Network of Fertility Centers, to Offer FemaSeed

30 Oct 2024 09:00:00 By Nasdaq GlobeNewswire

Femasys to Exhibit at ASRM 2024 and Participate in the Congress’ KEEPR Education Program

10 Oct 2024 08:30:00 By Nasdaq GlobeNewswire

Femasys to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

08 Oct 2024 08:30:00 By Nasdaq GlobeNewswire

Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility Treatments

02 Oct 2024 08:30:00 By Nasdaq GlobeNewswire

Femasys Announces Infertility Clinic Customers from Coast to Coast

18 Sep 2024 08:30:00 By Nasdaq GlobeNewswire

Femasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed® for over $1.3M in Spanish Market

11 Sep 2024 08:30:00 By Nasdaq GlobeNewswire